DE-ANRGs were engaged in 151 KEGG pathways, including the neurotrophin signaling pathway, glioma, T cell receptor signaling pathway, cellular senescence, and choline metabolism in cancer (Figure 1g, Table S4). This evidence concerns the gene BDNF and central nervous system cancer.